Exchange: NASDAQ·Updated 11:36 AM EDT
Latest Earnings Results: Q2 '26

Reported: Aug 05

Estimated EPS

-$0.09

Reported EPS

-$0.09

Surprise

+3.57%

Estimated Rev

$47.31M

Reported Rev

$48.14M

Surprise

+1.76%

• Reported GAAP EPS of -$0.09 down -125.00% YoY • Reported revenue of $48.14M up 5.57% YoY • Cytek Biosciences is updating its revenue outlook for the full year 2026 to be in the range of $207 million to $212 million, raising the midpoint by $1 million total.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Investor Presentation10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
-$0.07
--
--
N/A
Q2 '26
-$0.09
-$0.09
3.57%
BEAT
Q1 '26
-$0.09
-$0.15
-62.16%
MISSED
Q4 '25
-$0.02
-$0.34
-1600.00%
MISSED
Q3 '25
-$0.03
$0.00
114.01%
BEAT

Advertisement|Remove ads.